Christina Elaine Bray - 01 Nov 2022 Form 3 Insider Report for BIOLARGO, INC. (BLGO)

Role
Director
Signature
/s/ John R. Browning, Attorney-in-fact
Issuer symbol
BLGO
Transactions as of
01 Nov 2022
Net transactions value
$0
Form type
3
Filing time
10 Nov 2022, 18:34:29 UTC
Next filing
05 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BLGO Option to Purchase Common Stock 01 Nov 2022 Common Stock 100,000 $0.2436 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was issued November 1, 2022, and vests in four quarterly installments beginning January 1, 2023, provided Reporting Person remains a member of Issuer's board of directors.